Acid-induced conformational changes in phosphoglucose isomerase result in its increased cell surface association and deposition on fibronectin fibrils

被引:9
作者
Amraei, M
Jia, ZJ
Reboul, P
Nabi, IR
机构
[1] Univ Montreal, Dept Pathol & Biol Cellulaire, Montreal, PQ H3C 3J7, Canada
[2] Univ Montreal, Ctr Hosp, Hop Notre Dame, Osteoarthrit Res Unit, Montreal, PQ H2L 4M1, Canada
关键词
D O I
10.1074/jbc.M304778200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Phosphoglucose isomerase (PGI) is a glycolytic enzyme that exhibits extracellular cytokine activity as autocrine motility factor, neuroleukin, and maturation factor and that has been recently implicated as an autoantigen in rheumatoid arthritis. In contrast to its receptor-mediated endocytosis at neutral pH, addition of 25 mug/ml of either Alexa 568- or FITC-conjugated PGI to NIH-3T3 cells at progressively acid pH results in its quantitatively increased association with cell surface fibrillar structures that is particularly evident at pH 5. A similar pH-dependent cell surface association of PGI is observed for first passage human chondrocytes obtained from osteoarthritic joints. At acid pH, PGI colocalizes with fibronectin fibrils, and this association occurs directly upon addition of PGI to the cells. In contrast to the receptor-mediated endocytosis of PGI, fibril association of 25 mug/ml PGI at pH 5 is not competed with an excess (2 mg/ml) of unlabeled PGI. PGI binding at acid pH is therefore neither saturable nor mediated by its receptor. PGI is enzymatically active as a dimer and we show here by non-denaturing gel electrophoresis as well as by glutaraldehyde cross-linking that it exists at neutral pH in a tetrameric form. Increasingly acid pH results in the appearance of PGI monomers that correlates directly with its enhanced cell surface association. However, glutaraldehyde cross-linked PGI is endocytosed at neutral pH and still exhibits enhanced cell surface binding at pH 5. Circular dichroism analysis revealed pH-dependent changes in the near but not the far UV spectra indicating that the tertiary structure of the protein is specifically altered at pH 5. Conformational changes of PGI and exposure of the monomer-monomer interface under acidic conditions, such as those encountered in the synovial fluid of arthritic joints, could therefore result in its deposition on the surface of joints and the induction of an autoimmune response.
引用
收藏
页码:38935 / 38941
页数:7
相关论文
共 76 条
[1]
ACCOLA MA, 2002, J BIOL CHEM, DOI UNSP M201641200
[2]
DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE [J].
ALTMAN, R ;
ASCH, E ;
BLOCH, D ;
BOLE, G ;
BORENSTEIN, D ;
BRANDT, K ;
CHRISTY, W ;
COOKE, TD ;
GREENWALD, R ;
HOCHBERG, M ;
HOWELL, D ;
KAPLAN, D ;
KOOPMAN, W ;
LONGLEY, S ;
MANKIN, H ;
MCSHANE, DJ ;
MEDSGER, T ;
MEENAN, R ;
MIKKELSEN, W ;
MOSKOWITZ, R ;
MURPHY, W ;
ROTHSCHILD, B ;
SEGAL, M ;
SOKOLOFF, L ;
WOLFE, F .
ARTHRITIS AND RHEUMATISM, 1986, 29 (08) :1039-1049
[3]
Species specificity of the cytokine function of phosphoglucose isomerase [J].
Amraei, M ;
Nabi, IR .
FEBS LETTERS, 2002, 525 (1-3) :151-155
[4]
The crystal structure of rabbit phosphoglucose isomerase complexed with 5-phospho-D-arabinonohydroxamic acid [J].
Arsenieva, D ;
Hardré, R ;
Salmon, L ;
Jeffery, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (09) :5872-5877
[5]
Fibronectin fragments and their role in inflammatory arthritis [J].
Barilla, ML ;
Carsons, SE .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2000, 29 (04) :252-265
[6]
AUTOCRINE MOTILITY FACTOR-RECEPTOR IS A MARKER FOR A DISTINCT MEMBRANOUS TUBULAR ORGANELLE [J].
BENLIMAME, N ;
SIMARD, D ;
NABI, IR .
JOURNAL OF CELL BIOLOGY, 1995, 129 (02) :459-471
[7]
Localization of autocrine motility factor receptor to caveolae and clathrin-independent internalization of its ligand to smooth endoplasmic reticulum [J].
Benlimame, N ;
Le, PU ;
Nabi, IR .
MOLECULAR BIOLOGY OF THE CELL, 1998, 9 (07) :1773-1786
[8]
BLACKBURN MN, 1972, J BIOL CHEM, V247, P5668
[9]
BODANSKY O, 1954, CANCER, V7, P1200, DOI 10.1002/1097-0142(195411)7:6<1200::AID-CNCR2820070612>3.0.CO
[10]
2-9